CHINA-PHARM International Forum on Pharmaceutical Industry
Organizer
China Center for Pharmaceutical International Exchange of SFDA
Date & Venue
Nov.7-9, 2006
China International Exhibition Center
Audience
This forum is directly oriented toward the high level management and decision maker of pharmaceutical production enterprise, the professionals participating in production, control and supervisory management of pharmaceuticals including the manufacturing management personnel, processing / production engineers, production personnel, specialists in quality evaluation / quality control and pharmaceutical affairs, consultant, personnel for investigation on pharmaceutical affairs as well as cCMP official for verification. The other organizations or individuals, who are interested in this field, are also welcomed.
How to get more information
www.chinapharmex.com
Tel: 8610-66162161/66155332/66155603/66155632
Fax: 8610-66167891
Email: chinapharm@ccpie.org
Background
CHINA - PHARM Forum, sponsored by China Center for Pharmaceutical International Exchange under SFDA (State Food and Drug Administration), will be hosted in November, during which CHINA - PHARM will be held.
China International Pharmaceutical Exhibition ( CHINA - PHARM) has been held for 11 times. Every year, the specialists and officials from pharmaceutical industry both at home and abroad will meet here to jointly probe into the development of technology and equipment of pharmaceutical industry, discuss and study the relevant policies and laws and regulations, and make forecast and evaluation on the international high and new technologies. In order to cooperate the implementation of supervisory management by SFDA, promote the internationalization of manufacturing management by medicine production companies and boost the internationalization progress of Chinese Pharmaceutical Industry, the 2nd CHINA - PHARM Forum will be held during November 7-9, 2006.
In this forum lasting 3 days, the officials of pharmaceutical supervision and management authorities from America, Germany and China, international cGMP specialist as well as representatives from domestic famous pharmaceutical manufacturing enterprises will conduct exploratory investigation and intercommunion on the problems with respect to supervisory management of pharmaceuticals, put forward suggestions and opinions on the development of Chinese manufacturing enterprises, providing the reference for the establishment of laws and regulations on pharmaceutical management of China.
Schedule
CHINA-PHARM Main Forum----Regulations and Technology
A.M ， November 7 ( Tuesday), Opening Session
Subject ：The development of policy for pharmaceutical industry and international communication as well as the corresponding measures to be adopted by pharmaceutical enterprises
　　SFDA: To observe cGMP from the view of supervision and control by the Chinese Government
CGMP certification of Germany
SDA Site inspection
　　
P.M ， November 7 ( Tuesday)
Subject ： High and new technologies for medicine production
　　The development and application of production equipment for Chinese traditional medicine
　　Construction and management of factory buildings
　　Detection technique--The guarantee for pharmaceutical safety
　　
A.M, November 8 (Wednesday)
Subject ： The way to API certification
　　API in cGMP
　　The situation and problems regarding field inspection
　　Cases of pharmaceutical manufactures





　　
　　
Second Forum----Pharma & Drug Packing Material Technology
　　
P.M, November 8 (Wednesday)
Subject ：Inspection and Development on the Packaging of Drugs and Food
Regulation History and Future
Introduction to the rules
Food Safety and Packaging

A.M, November 9 (Thursday)
Subject ：Pharmaceutical packaging material and forgery prevention technology
The Actuality and Trend in the world at the Pharmaceutical Packaging Technology
Solid
Liquid

P.M, November 9 (Thursday)
Subject ：Forgery prevention and Safety Production
Stability Experiment on Drug Packaging
Forgery prevention
Development Situation and Trend of Drugs and Food Packaging Industry in China

文章来源: CHINA-PHARM International Forum on Pharmaceutical Industry